Tag: Prescription Drugs
Study Looks at Abortion Rates With No-Test Telehealth Screening, Meds Mailing
Similar rates of complete abortion seen for no-test screening and mailing of mifepristone when compared with in-person care
Granting Waiver for Cancer Treatment Does Not Affect Safety, Efficacy Outcomes
Similar serious adverse event rate, clinical benefit seen for patients with versus those without a waiver
Study Compares Rivaroxaban, Warfarin With Apixaban for Cirrhosis, A-Fib
Initiators of rivaroxaban or warfarin versus apixaban have significantly higher rates of major hemorrhage
FDA Approves New Drug to Treat Alzheimer’s
Amivantamab-Lazertinib Ups Survival in EGFR-Mutated Advanced Lung Cancer
Improved progression-free survival seen for amivantamab-lazertinib versus osimertinib as first-line treatment
NCCN: Cancer Drug Shortages Remain a Challenge for Clinicians
89 percent of cancer centers report that cancer drugs are in short supply, most often vinblastine, etoposide, and topotecan
Only One-Quarter of Adults Who Needed Opioid Use Disorder Meds in 2022 Received Them
Higher percentages of men and adults aged 35 to 49 years received medications for opioid use disorder
Histologic Response Up With Benralizumab for Eosinophilic Esophagitis
Significantly more patients had histologic response with benralizumab than placebo, but no significant difference seen in dysphagia symptoms
Dupilumab Ups Histologic Response for Pediatric Eosinophilic Esophagitis
Significant improvements seen in histologic, endoscopic, and transcriptomic measures in higher-exposure dupilumab regimen
PIK3CA Could Guide Use of COX-2 Inhibitors in Treatment for Colon Cancer
Patients with stage III resected colon cancer with PIK3CA gain-of-function mutations treated with celecoxib had improved DFS, OS
